Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/16/2012WO2012109280A2 Apoe immunotherapy
08/16/2012WO2012109243A2 Method of treating intercellular barrier dysfunction
08/16/2012WO2012109203A1 Adjuvant compositions with 4-ibbl
08/16/2012WO2012109167A1 Immunogenic composition comprising alpha-hemolysin oligopeptides
08/16/2012WO2012108851A1 Composition for the treatment of suppurating wounds
08/16/2012WO2012108840A1 A novel expression cassette for efficient surface display of antigenic proteins
08/16/2012WO2012108782A1 Antibody that stops or slows tumour growth (variants)
08/16/2012WO2012108650A2 Uses of a monoclonal antibody to proteinase-3 as a therapeutic agent or as a diagnostic agent for a stroke
08/16/2012WO2012107747A1 Antigenic gly1 polypeptides
08/16/2012WO2012107746A1 Antigenic gly1 polypeptide
08/16/2012WO2012107614A1 Vaccine against african swine fever virus, based on replication deficient recombinant viruses
08/16/2012WO2012107531A1 B-type plexin antagonists and uses thereof
08/16/2012WO2012107424A1 Anti-gb3 antibodies useful in treating disorders associated with angiogenesis
08/16/2012WO2012107417A1 Mutant interleukin-2 polypeptides
08/16/2012WO2012107211A1 Anti-alpha-v integrin antibody for the treatment of prostate cancer
08/16/2012WO2012085936A8 Recombinant respiratory syncytial virus plasmids and vaccines
08/16/2012WO2012076756A3 Pharmaceutical compositions comprising 8-substituted dibenzylbutyrolactone lignans
08/16/2012WO2012075379A3 Liquid viral formulations
08/16/2012WO2012075376A3 Lyophilized viral formulations
08/16/2012WO2012071561A3 Anti-il-6 antibodies for the treatment of anemia
08/16/2012WO2012071554A3 Anti-il-6 antibodies for the treatment of oral mucositis
08/16/2012WO2012071411A3 Nk cell modulating treatments and methods for treatment of hematological malignancies
08/16/2012WO2012068456A3 Compositions and methods for treating obesity
08/16/2012WO2012058592A3 Non-antagonistic egfr-binding molecules and immunoconjugates thereof
08/16/2012WO2012054920A3 Antigen-specific, tolerance-inducing microparticles and uses thereof
08/16/2012WO2012053828A3 Human interleukin-1 receptor antagonist - hybrid fc fusion protein
08/16/2012WO2012031122A3 Methods and compositions for the diagnosis and treatment of cancer and autoimmune disorders
08/16/2012WO2012027721A3 Antibodies to matrix metalloproteinase 9
08/16/2012WO2012027473A3 Immunogenic compositions comprising alphavirus vectored dengue virus e protein antigens
08/16/2012WO2012019125A3 Biomarkers for prostate cancer and methods for their detection
08/16/2012WO2012012531A3 Compositions and methods featuring il-6 and il-21 antagonists
08/16/2012WO2011159928A3 Anti-dr4 agonist antibodies
08/16/2012WO2010055366A4 Anti-human il-21 monoclonal antibodies
08/16/2012US20120210465 Production of Polyunsaturated Fatty Acids, Novel Biosynthesis Genes, And Novel Plant Expression Constructs
08/16/2012US20120208870 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene
08/16/2012US20120208862 Rip140 regulation of glucose transport
08/16/2012US20120208854 Therapeutic combination
08/16/2012US20120208774 Method for inhibiting "melanoma inhibitory activity" mia
08/16/2012US20120207819 Compositions and methods for wound healing
08/16/2012US20120207815 Method of treating eosinophilic esophagitis
08/16/2012US20120207809 Method and system for effecting changes in pigmented tissue
08/16/2012US20120207799 Oral delivery vehicle and material
08/16/2012US20120207788 Hypoallergenic hybrid polypeptides for the treatment of allergy
08/16/2012US20120207787 Animal Protein-Free Pharmaceutical Compositions
08/16/2012US20120207786 Functional influenza virus-like particles (vlps)
08/16/2012US20120207785 Process for preparing an influenza seed virus for vaccine manufacture
08/16/2012US20120207784 Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine
08/16/2012US20120207783 Hiv vaccine formulations
08/16/2012US20120207782 Hiv dna vaccine regulated by a caev-derived promoter
08/16/2012US20120207781 Dimensional analysis of saccharide conjugates with gpc & sec mals
08/16/2012US20120207780 Vaccine Composition
08/16/2012US20120207779 Anaplasma phagocytophilum (Aph) Antigens and Antibodies Specific for Anaplasma
08/16/2012US20120207778 Nucleic acids and proteins from streptococcus groups a and b
08/16/2012US20120207777 Detoxified escherichia coli immunogens
08/16/2012US20120207776 Conserved escherichia coli immunogens
08/16/2012US20120207775 Immunogenic Epitopes as Targets for Universal Cancer Vaccines
08/16/2012US20120207774 Immunization of fish with plant-expressed recombinant proteins
08/16/2012US20120207773 Materials and methods for the development of an antigen-specific immune non-responsiveness state
08/16/2012US20120207772 Anti-muc1 alpha/beta antibodies
08/16/2012US20120207771 Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
08/16/2012US20120207770 Antiproliferative agent
08/16/2012US20120207769 Inhibitors of IAP
08/16/2012US20120207768 Cd38 and obesity
08/16/2012US20120207767 Combined Treatment with an EGFR Kinase Inhibitor and an Agent that Sensitizes Tumor Cells to the Effects of EGFR Kinase Inhibitors
08/16/2012US20120207766 Intracellular toll-like receptors pathways and axonal degeneration
08/16/2012US20120207765 Chemokine receptor antagonists and use thereof
08/16/2012US20120207764 Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and methods for using anti-ptk7 antibodies
08/16/2012US20120207763 Pyrrolopyrimidine compounds and their uses
08/16/2012US20120207762 Stable pharmaceutical formulations
08/16/2012US20120207761 Anti-il-22ra antibodies and binding partners and methods of using in inflammation
08/16/2012US20120207760 Compositions and Methods for the Therapy and Diagnosis of Influenza
08/16/2012US20120207759 Compositions and methods for modulating lymphocyte activity
08/16/2012US20120207758 CD22 Exon 12 Deletion Mutants
08/16/2012US20120207757 Methods of antagonizing signal transduction in spinal cord cells
08/16/2012US20120207756 Modified Antibody Compositions, Methods of Making and Using Thereof
08/16/2012US20120207755 Cancer
08/16/2012US20120207754 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
08/16/2012US20120207753 Methods of using cd44 fusion proteins to treat cancer
08/16/2012US20120207752 Methods for modulating il-33 activity
08/16/2012US20120207751 Imidazoquinolines as lipid kinase inhibitors
08/16/2012US20120207750 Antibodies against human tweak and uses thereof
08/16/2012US20120207749 Dosing regimen
08/16/2012US20120207748 T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy
08/16/2012US20120207747 Anti-ephb4 antibodies and methods using same
08/16/2012US20120207746 Anti-C epsilon mX antibodies capable of binding to human mIgE on B Lymphocytes
08/16/2012US20120207745 Composition to Induce Specific Immune Tolerance
08/16/2012US20120207744 Reprogramming compositions and methods of using the same
08/16/2012US20120207709 Hbv antisense inhibitors
08/16/2012US20120207708 Biomarkers for cancer-related fatigue and use thereof
08/16/2012US20120207706 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same
08/16/2012US20120207682 Methods of treating macular edema using antiedema therapeutics
08/16/2012US20120207673 Modified Variable Domain Molecules And Methods For Producing And Using Same
08/16/2012US20120207671 Combination treatment with vegf-c antagonists
08/16/2012US20120207670 Method for Treating Psoriasis by Administering An Anti-IL-12 Antibody
08/16/2012DE102009056883B4 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben Vaccine adjuvants and to improved methods for the preparation thereof
08/16/2012CA2841404A1 Treatment of angiogenesis disorders
08/16/2012CA2827150A1 Yeast-based therapeutic for chronic hepatitis b infection
08/16/2012CA2827082A1 Methods of treating macular edema using antiedema therapeutics
08/16/2012CA2827080A1 Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same
08/16/2012CA2827052A1 Anti-alpha-v integrin antibody for the treatment of prostate cancer
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 1823